Evaluation of plasma glucose change by Libre Pro shortly after hospital discharge in type 2 diabetes with multiple daily insulin injection method

Evaluation of plasma glucose change by Libre Pro shortly after hospital discharge in type 2 diabetes with multiple daily insulin injection method - DISCHARGe study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035148

Enrollment

Registered

2018-12-05

Start date

2018-12-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with HbA1c above 9.0% (2) Patients introduced multiple daily insulin injection method during hospitalization (3) Patients who is not in insulin dependence state (4) Patients who has insulin requirement >= 15 units/day (5) Patients whose plasma glucose daily fluctuation is stable (6) Patients who can understand consent brief and other explanation documents having the ability of the agreement about participation in this trial

Exclusion criteria

Exclusion criteria: (1) Type 1 diabetes mellitus patients (2) Patients with severe liver disease (3) Patients with severe renal disease (4) Patients who had myocardial infarction within 3 months, or obvious heart failure case (5) Patients with severe pancreas disease (6) Patients having a cancer (7) Patients with hemoglobin (Hb) less than 11 g/dL (8) Patients that the number of the platelets is less than 100,000 /mm3 (9) Patients with high diabetic neuropathy (10) Patients having a proliferative retinopathy (11) Patients with a serious infectious disease or a serious injury (12) Patients with bowel disease or ileus factors (13) Chronic enteropathy patients with the digestion and absorption abnormality (14) Excessive common custom drinker (15) A pregnant woman or the woman who may be pregnant (16) Patients who was infected with hepatitis B virus or hepatitis C virus (17) In addition, the patient who judged inappropriate by an attendant physician

Design outcomes

Primary

Measure	Time frame
Hypoglycemia (value, frequency, appearance time and duration)	—

Secondary

Measure	Time frame
Changes in the amount of insulin, Difference due to insulin preparation	—

Countries

Japan

Contacts

Public ContactMasahiko Miyagi

Toho University Omori Medical Center Hospital Diabetes, Metabolism and Endocrinology Center

miyagi-m@med.toho-u.ac.jp03-3762-4151

Outcome results